Moreover, the SLC25A1 inhibition enhanced the sensitivity to cisplatin in ovarian carcinoma cells and increased the radiosensitivity of hypoxic lung cancer cells [14]. The gene discussed is SLC25A1; the disease is lung carcinoma.